• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用减毒炭疽毒素递送的抗病毒小干扰RNA可保护细胞免受寨卡病毒的细胞病变效应影响。

Antiviral siRNA delivered using attenuated, anthrax toxin protects cells from the cytopathic effects of Zika virus.

作者信息

Feron Benedita K L, Gomez Timothy, Youens Natalie C, Mahmoud Nourhan A M, Abdelrahman Hadeer K S, Bugert Joachim J, Richardson Simon C W

机构信息

Exogenix Laboratory, School of Science, University of Greenwich, Central Avenue, Chatham, Kent, ME4 4TB, UK.

Department of Biochemistry, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza, 12451, Egypt.

出版信息

Virus Genes. 2025 Jun;61(3):342-354. doi: 10.1007/s11262-025-02152-4. Epub 2025 Mar 30.

DOI:10.1007/s11262-025-02152-4
PMID:40159353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12053335/
Abstract

Curative drugs are needed for the treatment of viral infections. Small interfering (si)RNA offer such a prospect but require the development of safe, effective and non-hepatotropic subcellular delivery systems. Here, 5 candidate siRNA molecules targeting defined sequences within the Zika Virus (ZIKV) genome were assayed for their ability to reduce ZIKV induced cytopathic effects in vitro. The protection of Huh-7 cells from ZIKV cytopathic effects was recorded after electroporation and the siRNA Feron-Zv2, resulting in 122.7 ± 5.3% cell viability (n = 3 ± standard error of the mean (SEM), 100 nM siRNA) after exposure to ZIKV relative to a virus treated control (35.2 ± 7.1% cell viability (n = 3 ± SEM)). Protection of BHK-21 cells was recorded after transfection with an attenuated anthrax toxin containing an RNA binding domain. Treatment with Feron-Zv4 resulted in 75.1 ± 2.9% cell viability (n = 3 ± SEM, 25 nM siRNA) after exposure to ZIKV. This protection was mirrored by a system containing octameric PA where a maximum of 86.2 ± 4.4% cell viability was reported (n = 3 ± SEM, 75 nM siRNA) after treatment with Feron-Zv2. Scrambled siRNA afforded no measurable protection. Here we report for the first time that siRNA delivered by either attenuated anthrax toxin or octamer forming ATx can protect mammalian cells from ZIKV cytopathic effects.

摘要

治疗病毒感染需要有治愈性药物。小干扰(si)RNA提供了这样一种前景,但需要开发安全、有效且非嗜肝性的亚细胞递送系统。在此,对5种靶向寨卡病毒(ZIKV)基因组内特定序列的候选siRNA分子进行了检测,以评估它们在体外降低ZIKV诱导的细胞病变效应的能力。在电穿孔后记录了Huh-7细胞免受ZIKV细胞病变效应的情况,以及siRNA Feron-Zv2的作用,相对于病毒处理的对照(细胞活力为35.2±7.1%(n = 3±平均标准误差(SEM))),在暴露于ZIKV后,Feron-Zv2导致细胞活力达到122.7±5.3%(n = 3±SEM,100 nM siRNA)。在用含有RNA结合结构域的减毒炭疽毒素转染后,记录了BHK-21细胞的保护情况。用Feron-Zv4处理后,在暴露于ZIKV后细胞活力为75.1±2.9%(n = 3±SEM,25 nM siRNA)。这种保护作用在一个含有八聚体PA的系统中得到了体现,在用Feron-Zv2处理后,报告的最大细胞活力为86.2±4.4%(n = 3±SEM,75 nM siRNA)。乱序siRNA没有提供可测量的保护作用。在此,我们首次报告,由减毒炭疽毒素或形成八聚体的ATx递送的siRNA可以保护哺乳动物细胞免受ZIKV细胞病变效应的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/3ebf3642602f/11262_2025_2152_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/bf84e241d33b/11262_2025_2152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/ae92eaa5caf9/11262_2025_2152_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/de2e12f15390/11262_2025_2152_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/c266c7069ee6/11262_2025_2152_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/041041c93c91/11262_2025_2152_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/3ebf3642602f/11262_2025_2152_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/bf84e241d33b/11262_2025_2152_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/ae92eaa5caf9/11262_2025_2152_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/de2e12f15390/11262_2025_2152_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/c266c7069ee6/11262_2025_2152_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/041041c93c91/11262_2025_2152_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c299/12053335/3ebf3642602f/11262_2025_2152_Fig6_HTML.jpg

相似文献

1
Antiviral siRNA delivered using attenuated, anthrax toxin protects cells from the cytopathic effects of Zika virus.使用减毒炭疽毒素递送的抗病毒小干扰RNA可保护细胞免受寨卡病毒的细胞病变效应影响。
Virus Genes. 2025 Jun;61(3):342-354. doi: 10.1007/s11262-025-02152-4. Epub 2025 Mar 30.
2
Disarmed anthrax toxin delivers antisense oligonucleotides and siRNA with high efficiency and low toxicity.去毒炭疽毒素高效低毒传递反义寡核苷酸和 siRNA。
J Control Release. 2015 Dec 28;220(Pt A):316-328. doi: 10.1016/j.jconrel.2015.10.054. Epub 2015 Nov 9.
3
Palmatine inhibits Zika virus infection by disrupting virus binding, entry, and stability.荷叶碱通过破坏病毒结合、进入和稳定性来抑制寨卡病毒感染。
Biochem Biophys Res Commun. 2019 Oct 22;518(4):732-738. doi: 10.1016/j.bbrc.2019.08.120. Epub 2019 Aug 28.
4
Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.使用基于细胞的高通量筛选试验评估广谱抗病毒药物和美国国立卫生研究院临床收集化合物的抗寨卡病毒活性。
Antiviral Res. 2017 Feb;138:47-56. doi: 10.1016/j.antiviral.2016.11.018. Epub 2016 Dec 3.
5
The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy.塞来昔布衍生物激酶抑制剂 AR-12(OSU-03012)通过下调 PI3K/Akt 通路抑制寨卡病毒,并保护感染寨卡病毒的 A129 小鼠:一种针对宿主的治疗策略。
Antiviral Res. 2018 Dec;160:38-47. doi: 10.1016/j.antiviral.2018.10.007. Epub 2018 Oct 13.
6
Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.非核苷类 Zika 病毒 RNA 依赖性 RNA 聚合酶抑制剂。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.00794-20.
7
Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika Virus.开发和验证一种表型高内涵成像分析方法,用于评估针对寨卡病毒的小分子抑制剂的抗病毒活性。
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.00725-18. Print 2018 Oct.
8
Zika virus cell tropism in the developing human brain and inhibition by azithromycin.寨卡病毒在发育中的人类大脑中的细胞嗜性及阿奇霉素对其的抑制作用
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14408-14413. doi: 10.1073/pnas.1618029113. Epub 2016 Nov 29.
9
Atlastin Endoplasmic Reticulum-Shaping Proteins Facilitate Zika Virus Replication.在内质网成形蛋白的帮助下,寨卡病毒得以复制。
J Virol. 2019 Nov 13;93(23). doi: 10.1128/JVI.01047-19. Print 2019 Dec 1.
10
Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro.甘草次酸衍生物作为寨卡病毒抑制剂的研究:体外合成与抗病毒活性。
Bioorg Med Chem. 2021 Jul 1;41:116204. doi: 10.1016/j.bmc.2021.116204. Epub 2021 May 10.

本文引用的文献

1
Influenza vaccination for children in Europe: The health of every child matters.欧洲儿童流感疫苗接种:每个孩子的健康都至关重要。
Vaccine. 2025 Feb 6;46:126675. doi: 10.1016/j.vaccine.2024.126675. Epub 2024 Dec 27.
2
Celebrating vaccines: The 2023 Nobel prize in medicine or physiology.庆祝疫苗:2023年诺贝尔生理学或医学奖
Vaccine. 2024 Mar 7;42(7):1409-1410. doi: 10.1016/j.vaccine.2023.10.056. Epub 2024 Feb 15.
3
siRNA lipid nanoparticles for CXCL12 silencing modulate brain immune response during Zika infection.用于沉默 CXCL12 的 siRNA 脂质纳米颗粒在寨卡病毒感染期间调节大脑免疫反应。
Biomed Pharmacother. 2024 Jan;170:115981. doi: 10.1016/j.biopha.2023.115981. Epub 2023 Dec 12.
4
Zika Virus (ZIKV): A New Perspective on the Nanomechanical and Structural Properties.寨卡病毒(ZIKV):纳米力学和结构特性的新视角。
Viruses. 2022 Aug 5;14(8):1727. doi: 10.3390/v14081727.
5
The Delivery of mRNA Vaccines for Therapeutics.用于治疗的信使核糖核酸疫苗的递送
Life (Basel). 2022 Aug 17;12(8):1254. doi: 10.3390/life12081254.
6
CHIKV strains Brazil (wt) and Ross (lab-adapted) differ with regard to cell host range and antiviral sensitivity and show CPE in human glioblastoma cell lines U138 and U251.基孔肯雅病毒(CHIKV)的巴西(野生型)毒株和罗斯(实验室适应型)毒株在细胞宿主范围和抗病毒敏感性方面存在差异,并且在人胶质母细胞瘤细胞系U138和U251中表现出细胞病变效应。
Virus Genes. 2022 Jun;58(3):188-202. doi: 10.1007/s11262-022-01892-x. Epub 2022 Mar 26.
7
Drug delivery systems for RNA therapeutics.RNA 治疗药物的递药系统。
Nat Rev Genet. 2022 May;23(5):265-280. doi: 10.1038/s41576-021-00439-4. Epub 2022 Jan 4.
8
sEVs selectively delivers antiviral siRNA to fetus brain, inhibits ZIKV infection and mitigates ZIKV-induced microcephaly in mouse model.外泌体能够有选择地将抗病毒 siRNA 递送到胎儿大脑,抑制寨卡病毒感染,并减轻寨卡病毒诱导的小鼠模型中的小头畸形。
Mol Ther. 2022 May 4;30(5):2078-2091. doi: 10.1016/j.ymthe.2021.10.009. Epub 2021 Nov 10.
9
CRISPA: A Non-viral, Transient Cas9 Delivery System Based on Reengineered Anthrax Toxin.CRISPA:一种基于改造后的炭疽毒素的非病毒瞬时Cas9递送系统。
Front Pharmacol. 2021 Oct 18;12:770283. doi: 10.3389/fphar.2021.770283. eCollection 2021.
10
Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and Prospects.基因治疗中的非病毒载体:最新进展、挑战与展望。
AAPS J. 2021 Jun 2;23(4):78. doi: 10.1208/s12248-021-00608-7.